Juvenile Arthritis Awareness Month

Every July, communities across the country recognize Juvenile Arthritis (JA) Awareness Month to shine a light on the children and families living with this condition. The goal is to raise awareness that arthritis is not only an adult disease. Children can develop it too, sometimes as early as infancy.

What Is Juvenile Arthritis?

Juvenile arthritis (JA) is an umbrella term used to describe several types of arthritis and related autoimmune or inflammatory conditions that develop in children under the age of 16. The most common form is juvenile idiopathic arthritis (JIA). "Idiopathic" means the exact cause is unknown.

In juvenile idiopathic arthritis, the immune system mistakenly attacks healthy tissues, particularly the joints, causing chronic inflammation. If left untreated, persistent inflammation can lead to joint damage, impaired growth, vision problems, and other complications.

Who Is Affected?

Juvenile arthritis affects about 1 in every 1,000 children and can occur in infants, children, and teenagers of all races and ethnic backgrounds. Although anyone can develop the condition, certain forms are more common in girls than boys. Some forms can affect the eyes or other parts of the body, and the severity can vary widely. Children may experience mild symptoms with only a few joints involved, or they may develop more persistent, widespread disease requiring long-term treatment.

What Causes Juvenile Arthritis?

The exact cause of juvenile idiopathic arthritis remains unknown. Researchers believe it develops from a combination of genetic susceptibility and environmental triggers that cause the immune system to malfunction. Instead of protecting the body from infection, the immune system attacks healthy joint tissue, resulting in chronic inflammation. Juvenile arthritis is not contagious, and it is not caused by injury, poor diet, or physical activity.

Risk Factors

Although the precise cause is unknown, several factors may increase the likelihood of developing juvenile arthritis:

• Family history of autoimmune diseases

• Certain inherited genetic markers

• Female sex (for several subtypes of JIA)

• Age, as different subtypes tend to occur during specific childhood age groups

• Environmental factors may trigger an abnormal immune response in genetically susceptible children

  
  

Common Signs and Symptoms

Symptoms can vary depending on the type of juvenile arthritis and may fluctuate over time.

Common signs and symptoms include:

• Joint pain

• Joint swelling

• Joint stiffness, especially in the morning

• Warm or tender joints

• Limping, particularly after waking up

• Fatigue

• Fever

• Skin rash

• Swollen lymph nodes

• Decreased physical activity

• Eye inflammation (uveitis) or blurred vision

• Inflammation of the membranes surrounding the heart (pericarditis) or lungs (pleuritis)

• Growth problems or weight loss if inflammation is prolonged

How Is Juvenile Arthritis Diagnosed?

There is no single test that confirms juvenile idiopathic arthritis. Diagnosis involves a comprehensive evaluation by a healthcare provider, often including a pediatric rheumatologist. The evaluation may include:

• Detailed medical history

• Physical examination

• Assessment of symptoms lasting at least six weeks

• Blood tests to evaluate inflammation and autoimmune markers

• Imaging studies such as X-rays, ultrasound, or MRI to assess joint inflammation and damage

• Eye examinations to screen for uveitis, even when no eye symptoms are present

Because several other conditions can mimic juvenile arthritis, healthcare providers work to rule out infections, injuries, and other autoimmune diseases before making the diagnosis.

Treatment Options

Although there is currently no cure for juvenile idiopathic arthritis, effective treatments can control inflammation, relieve symptoms, protect joints, and help children remain active.

Treatment plans are individualized and may include:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation

• Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate

• Biologic medications that target specific parts of the immune system

• Corticosteroids for short-term control of severe inflammation

• Physical therapy to improve strength, flexibility, and joint function

• Occupational therapy to support daily activities

• Regular exercise and physical activity as recommended by healthcare providers

• Routine eye examinations to detect and treat uveitis early

• Ongoing monitoring by a pediatric rheumatology team

Why Awareness Matters

Living with juvenile arthritis involves more than managing joint pain. Children may face physical limitations, frequent medical appointments, medication side effects, emotional challenges, and disruptions to school and social activities. Raising awareness helps improve understanding, reduces misconceptions, encourages earlier diagnosis, and supports continued research into better treatments and, ultimately, a cure. Juvenile Arthritis Awareness Month is more than a calendar observance—it is a chance to advocate for children living with pain that others may not see.

For information about other chronic health conditions and how to promote wellness for the body, mind, and soul please visit Nurture Your Whole Self.

References

• John Hopkins Medicine

• Cleveland Clinic

• American College of Rheumatology

• Arthritis Foundation